Mark Murcko
Founder en RELAY THERAPEUTICS, INC. .
Fortuna: 8 M $ al 31/03/2024
Perfil
Mark Murcko is the founder of Relay Therapeutics, Inc. (founded in 2015) and holds the title of Director.
He is currently a Director at Octant, Inc., Morphic Therapeutic, Inc., Quentis Therapeutics, Inc., Dewpoint Therapeutics, Inc., Quvium UK Ltd., Biohybrid Solutions Holding, Inc., Human Immunology Biosciences, Inc., and a Trustee at Gordon Research Conferences.
Dr. Murcko has also held positions as a Director at SQZ Biotechnologies Co. and HIBio, Inc., as well as Chief Technology Officer & Vice President at Vertex Pharmaceuticals, Inc. and Senior Vice President-Strategy at Schrödinger, Inc. He obtained a doctorate degree from Yale University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC.
0.76% | 31/05/2023 | 996 952 ( 0.76% ) | 8 M $ | 31/03/2024 |
Cargos activos de Mark Murcko
| Empresas | Cargo | Inicio |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Founder | 04/05/2015 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | - |
Quentis Therapeutics, Inc.
 Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | Director/Board Member | 02/10/2018 |
Quvium UK Ltd.
 Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | Director/Board Member | 07/11/2014 |
| Gordon Research Conferences | Director/Board Member | - |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Director/Board Member | 01/11/2018 |
Octant, Inc.
 Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | Director/Board Member | - |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Director/Board Member | - |
Biohybrid Solutions Holding, Inc.
 Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Director/Board Member | - |
Antiguos cargos conocidos de Mark Murcko.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Mark Murcko.
| Yale University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| RELAY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | Commercial Services |
| Gordon Research Conferences | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Quentis Therapeutics, Inc.
Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | Health Technology |
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology HIBio, Inc. is a clinical immunology company that leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases. The company is based in South San Francisco, CA. HIBio is excited to work as part of a collaborative team. HIBio was founded by Tim Behrens and Travis Murdoch, with Travis Murdoch serving as the CEO since incorporation. | Health Technology |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Murcko
